The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website - Test2 - elhamkhani - TriplyDB

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

http://www.wikidata.org/entity/Q24645514

about

3,3'-Diindolylmethane induces G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia cells U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line From bytes to bedside: data integration and computational biology for translational cancer research Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa Mutations affecting the BHLHA9 DNA-binding domain cause MSSD, mesoaxial synostotic syndactyly with phalangeal reduction, Malik-Percin type SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2 ChimerDB--a knowledgebase for fusion sequences.Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes ChimerDB 2.0--a knowledgebase for fusion genes updated Characterizing the cancer genome in lung adenocarcinoma.COSMIC 2005 Comprehensive genomic characterization defines human glioblastoma genes and core pathways Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers Big Data: the challenge for small research groups in the era of cancer genomics Oncogenomic portals for the visualization and analysis of genome-wide cancer data Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?Visualizing multidimensional cancer genomics data To live or let die - complexity within the E2F1 pathway The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas Reconstructing skin cancers using animal models A quantitative comparison of human HT-1080 fibrosarcoma cells and primary human dermal fibroblasts identifies a 3D migration mechanism with properties unique to the transformed phenotype A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia The BAH domain of Rsc2 is a histone H3 binding domain The structural mechanism of KCNH-channel regulation by the eag domain.Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system.Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors.Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.Metabolic rewiring in melanoma Next-Generation Sequencing in Intellectual Disability GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1 PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

P2860

Q21134621-BBC9D14A-A82F-4FD8-BEAC-64DF62B055D8 Q21144984-D3CD4C28-9850-4E16-A4ED-529E11EBEA86 Q21145672-99160691-2592-434E-9A5B-EC7DE9773E54 Q21245316-8D60E255-9120-4FF8-B0A2-BA282AD45EE4 Q24307947-201EFE94-2479-469F-8006-931E4E954031 Q24316768-2770E147-C451-4EF9-A2A8-9CDE003514F3 Q24321572-8E9B30F1-F4DB-4121-843E-556651962EBC Q24538265-ECFFAF34-D24F-4B38-8BAD-B6B1D849F67D Q24595521-59E6448F-5A96-4CF8-B340-E15EE1F362BF Q24595981-83869CE4-D143-4EF3-921C-263AFB2F6B77 Q24644468-32970370-587A-440B-9D77-7123A67A6CBE Q24649926-A2CB5BD1-AFC7-4878-A7D8-6C9A2759FE42 Q24652464-E0407EEB-934F-4B33-BA3E-50E940149F41 Q24656128-69592420-FE91-4045-89A0-FC808A18C04D Q26751724-E29D51F3-230A-43E0-B764-E4141906BC44 Q26766271-E00188AD-237D-469A-AD1A-CC5DE76941E8 Q26780460-AF334C54-8BAC-4B90-B3A5-4F7797747363 Q26781295-5E3D6E10-6400-479A-BEB3-F678CD9883A3 Q26828860-50DA3871-EF2B-4618-BB9F-F514912159B4 Q26828992-54D20D12-A241-4D83-B135-AD2BC91462F3 Q26830362-91C33E3C-A55E-408D-8D56-A13F6B6FD326 Q26860645-96D6F2B5-E3DC-49CB-BA69-2CCDDDBE3E34 Q26862588-5CB71F0E-5368-4922-8A85-64ECA60310E3 Q27021883-84426B75-7C4F-44DD-B58A-95B997C6DF7A Q27024320-816DEDDE-9B95-449E-BB95-4604D341996B Q27300951-F8F07254-E6D2-4B68-BEF0-9296EBDB68E7 Q27321277-289936C2-ADCA-46E0-AA6F-5F79EFD5FD62 Q27679325-B17B37A6-90A2-4A76-B079-00F3F4BF9B41 Q27679796-A894C5E4-7740-4F31-92B6-C1E6D7A7B7AE Q27851856-8F1D68EB-8E8D-4B25-8553-5BA437ADBD25 Q27852473-72AFD9D8-50D1-4FE4-A7DB-AFCACB1789EF Q27852915-B1AE6998-77BC-48C2-A5B0-AB00D8CE61FC Q27852932-424947DA-2F24-4E90-A7B2-1F4C6455968D Q27853213-B1FC537D-CDDC-4E6F-AB97-D6B2A55EBEE6 Q27853234-73D5C1B7-9AE2-49FB-BF1F-EC11DB9D0262 Q28069081-4E2BFE45-372B-4C82-991D-294C4D4FA1AB Q28080074-2B89A24E-2D89-4A41-A752-C4EF35C15876 Q28080461-B113B0CD-90B3-4950-978A-EFFFEBA7050A Q28118221-1E14A479-04AF-4C83-935C-01904AD8E040 Q28247338-EF6E747A-2B27-4B16-8B63-BF77E6EE0028

P2860

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

http://www.wikidata.org/entity/Q24645514

description

2004 nî lūn-bûn

@nan

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@ast

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@en

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@nl

type

label

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@ast

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@en

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@nl

prefLabel

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@ast

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@en

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@nl

P1433

Q24645514-BC77262B-C63A-4378-A387-DF07CD6FFF79

P1476

Q24645514-BA0F16B7-6317-42C5-A279-8AFF41F389AB

P2093

Q24645514-16C50A66-0AC1-4322-AEDE-9C48081598EA

Q24645514-2740CFD1-48D5-45DC-8E9C-51280D94EE93

Q24645514-45CCEE3E-7B27-474B-B05F-86FB7EC66ED1

Q24645514-9CC0C0BB-54F8-4C35-97D8-CD51D9466CF0

Q24645514-B876316D-910D-4005-80DF-A454E32E1129

Q24645514-D1394824-7510-4D2B-8B57-E2FBFA678AA7

Q24645514-D9A28233-7E72-4D7B-8B81-E2E1EC0FDD6C

P2860

Q24645514-08CD3E03-63FA-4FB7-803C-F3110DBCB226

Q24645514-092ED2E3-F365-4A8B-88F5-58244142F10A

Q24645514-366D6065-B97B-47D3-BD62-D4C68C468129

Q24645514-5DC5492A-62CE-4BB9-861F-F118DF96A9E9

Q24645514-702E2B0E-2D9D-49E3-A82D-3867B4D9894E

Q24645514-77E358AD-EE44-4E04-8938-6FF771EBDFBE

Q24645514-902AD9BB-3C3D-4E2B-BD64-E996D21E5C24

Q24645514-95A15641-0E6F-43FC-866E-734605C1041C

Q24645514-96A85265-E3DC-44F4-9EAA-3F84912B8837

Q24645514-B4EE2864-EFB3-4ED0-BC4B-084EE85D3121

P2888

Q24645514-A495EBFB-557C-4301-9898-D3AB62132B3B

P304

Q24645514-F411692B-5CCD-40FA-A9E4-8CB19BDFF4E4

P31

Q24645514-F672BB6F-BC9E-4357-A273-9B7B3F3B46CA

P3181

Q24645514-AEB5E1E1-3D11-45C6-A509-5A73C62FF3A2

Q24645514-B221E83A-7EAA-4DF6-B6FB-3D5C72A4243D

P356

Q24645514-8C134114-C02A-4234-94EB-79C9F153D0C7

P407

Q24645514-31B67A7E-1CC9-4118-A54B-F80E9BB0A67A

P433

Q24645514-40631DEF-6F07-4DB9-9295-618729BD52BE

P478

Q24645514-00C320A0-8776-4009-B1C8-06AEEED4DC3C

P50

Q24645514-837EAD97-9021-47E5-A6F9-8752DE977397

Q24645514-B9242782-3E59-47BD-85D6-5AB6393F9E9B

Q24645514-D6F45A4F-56E4-43A9-B2BB-52446D99DB1B

Q24645514-F0C74F90-F9AA-4E0B-B3CB-6E54D4BEFE0D

P577

Q24645514-E849815F-F53A-4135-9F8A-9EC7EC355315

P5875

Q24645514-48FEFAD1-EB48-4CF5-98D2-2A098EED90D0

P6179

Q24645514-514A14DA-E069-42D3-B045-985341484030

P698

Q24645514-816B8DCA-0083-42C2-8EFE-D77DC4F4CC81

P921

Q24645514-BB3762AF-F6CB-4DE6-A1AF-5F2F26A4836F

P932

Q24645514-FBFFE717-1B4F-4682-9EF2-A14E90111104

P3181

P356

P1433

British Journal of Cancer

P1476

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

@en

P2093

A Dogan

http://www.w3.org/2001/XMLSchema#string

A Flanagan

http://www.w3.org/2001/XMLSchema#string

E Dawson

http://www.w3.org/2001/XMLSchema#string

J Clements

http://www.w3.org/2001/XMLSchema#string

R Pettett

http://www.w3.org/2001/XMLSchema#string

S Bamford

http://www.w3.org/2001/XMLSchema#string

S Forbes

http://www.w3.org/2001/XMLSchema#string

P2860

HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources

The Pfam protein families database

A census of human cancer genes

The Bioperl toolkit: Perl modules for the life sciences

Mutations of the BRAF gene in human cancer

The InterPro database, 2003 brings increased coverage and new features

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene

Database resources of the National Center for Biotechnology Information: update

Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1.

P2888

P304

355-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

92047

http://www.w3.org/2001/XMLSchema#string

936811

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJC.6601894

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Richard Wooster

P Andrew Futreal

Michael Stratton

P577

2004-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232759456

http://www.w3.org/2001/XMLSchema#string

P6179

1007395103

http://www.w3.org/2001/XMLSchema#string

P698

15188009

http://www.w3.org/2001/XMLSchema#string

P921

P932

2409828

http://www.w3.org/2001/XMLSchema#string